Time to re-evaluate sentinel node biopsy in melanoma post-multicenter selective lymphadenectomy trial
- PMID: 16361650
- DOI: 10.1200/JCO.2005.04.0147
Time to re-evaluate sentinel node biopsy in melanoma post-multicenter selective lymphadenectomy trial
Comment in
-
Research supports the view that sentinel node biopsy is the standard of care in high-risk primary melanoma.J Clin Oncol. 2006 Jun 20;24(18):2965-6; author reply 2966-7. doi: 10.1200/JCO.2006.06.5854. J Clin Oncol. 2006. PMID: 16782937 No abstract available.
Comment on
-
The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes.J Clin Oncol. 2005 Jul 20;23(21):4588-90. doi: 10.1200/JCO.2005.12.245. J Clin Oncol. 2005. PMID: 16034040 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
